AAA
KURA icon

Affinity Asset Advisors’s Kura Oncology KURA Stock Holding History

Affinity Asset Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-687,785
Closed -$13.4M – 92
2024
Q3 		$13.4M Buy
687,785
+37,785
+6% +$766K 1.83% 19
2024
Q2 		$13.4M Sell
650,000
-80,492
-11% -$1.65M 1.54% 19
2024
Q1 		$15.6M Buy
730,492
+538,957
+281% +$10.5M 1.93% 15
2023
Q4 		$2.75M Sell
191,535
-665,000
-78% -$6.54M 0.5% 50
2023
Q3 		$7.81M Sell
856,535
-53,782
-6% -$546K 2.2% 13
2023
Q2 		$9.63M Buy
910,317
+553,030
+155% +$6.54M 3.36% 10
2023
Q1 		$4.37M Buy
357,287
+88,540
+33% +$1.1M 1.44% 22
2022
Q4 		$3.34M Sell
268,747
-407,006
-60% -$5.92M 1.31% 26
2022
Q3 		$9.23M Sell
675,753
-252,503
-27% -$3.89M 2.58% 10
2022
Q2 		$17M Buy
928,256
+4,109
+0.4% +$59.1K 7.17% 2
2022
Q1 		$14.9M Buy
924,147
+364,147
+65% +$5.26M 2.38% 4
2021
Q4 		$7.84M Buy
560,000
+30,000
+6% +$486K 2.85% 11
2021
Q3 		$9.93M Buy
530,000
+105,000
+25% +$1.98M 2.51% 7
2021
Q2 		$8.86M Buy
425,000
+60,000
+16% +$1.49M 3.17% 8
2021
Q1 		$10.3M Buy
365,000
+105,000
+40% +$3.32M 3.5% 8
2020
Q4 		$8.49M Buy
+260,000
New +$9.14M 4.5% 5

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Affinity Asset Advisors's KURA Position: Q4 2024 in Review

Affinity Asset Advisors sold out of Kura Oncology (KURA) in Q4 2024, closing a stake of 687,785 shares — an estimated $13.4M sold.

Affinity Asset Advisors first reported a position in KURA in Q4 2020 and held it in 16 quarters. The position peaked at $17M in Q2 2022. 185 funds tracked by Wall St. Rank hold KURA as of Q4 2024.

  • Affinity Asset Advisors reported no remaining Kura Oncology position as of Q4 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 687,785 Kura Oncology shares in Q4 2024, an estimated $13.4M.
  • Affinity Asset Advisors first reported a position in Kura Oncology in Q4 2020 and held it in 16 quarters.
  • Affinity Asset Advisors's Kura Oncology position peaked at $17M in Q2 2022.
  • 185 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2024.

Based on Affinity Asset Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.